Functional abdominal pain

Postgraduate Medical Journal

Volumn 81, Issue 957, 2005, Pages 448-455

  Matthews, P J ^b   Aziz, Q ^a,b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; FLUOXETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; BEHAVIOR THERAPY; COGNITIVE THERAPY; DESENSITIZATION; DOCTOR PATIENT RELATION; DRUG ANTAGONISM; DRUG MEGADOSE; EVOKED CORTICAL RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROINTESTINAL DISEASE; HUMAN; HYPNOSIS; LOW DRUG DOSE; MAGNETOENCEPHALOGRAPHY; NEUROPHYSIOLOGY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIZATION; VISCERAL PAIN;

ABDOMINAL PAIN; COLONIC DISEASES, FUNCTIONAL; HUMANS; NEURAL PATHWAYS;

EID: 22344437913     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2004.030577     Document Type: Review

References (57)

1. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
2. Drossman DA, Corazziari E, Talley NJ, et al. Rome II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. 2nd ed. McLean, VA: Degnon Associates, 2000.
3. Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci l980;25:404-13.
4. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-93.
5. Collman PI, Tremblay L, Diamant NE. The distribution of spinal and vagal sensory neurons that innervate the esophagus of the cat. Gastroenterology 1992;103:817-22.
6. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9.
7. Aziz Q, Schnitzler A, Enck P. Functional neuroimaging of visceral sensation. J Clin Neurophysiol 2000;17:604-12.
8. Willis WD, Al-Chaer ED, Quast ME, et al. A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci U S A 1999;96:7675-9.
9. Al-Chaer ED, Feng Y, Willis WD. A role for the dorsal column in nociceptive visceral input into the thalamus of primates. J Neurophysiol 1998;79:3143-50.
10. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
11. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
12. Bercik P, Wang L, Verdue EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004;127:179-87.
13. Yiangou Y, Facer P, Baeker PA, et al. ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease. Neurogastroenterol Motil 2001;13:365-9.
14. Yiangou Y, Facer P, Dyer NH, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001;357:1338-9.
15. Yiangou Y, et al. Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol 2001;13:891-6.
16. Holzer P. Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol 2001;429:177-93.
17. Ji RR, Samad TA, Jin SX, et al. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains neat hyperalgesia. Neuron 2002;36:57-68.
18. Chan CL, Facer P, Davis JB, et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003;361:385-91.
19. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001;411:957-62.
20. Fu LW, Longhurst JC. Interleukin-1 beta sensitizes abdominal visceral afferents of cats to ischaemia and histamine. J Physiol 1999;521:249-60.
21. Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001;49:743-5.
22. Holtmann G, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004;126:971-9.
23. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
24. Willert RP, Woolfe CJ, Hobson AR, et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology 2004;126:683-92.
25. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56.
26. Verne GN, Price DD. Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep 2002;4:322-8.
27. Bernstein CN, Niazi N, Robert M, et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996;66:151-61.
28. Moriarty KJ, Dawson AM. Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) 1982;284:1670-2.
29. Sarkar S, Hobson AR, Furlong PL, et al. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2001;281:G1196-202.
30. Hobday DI, Hobson AR, Sarkar S, et al. Cortical processing of human gut sensation: an evoked potential study. Am J Physiol Gastrointest Liver Physiol 2002;283:G335-9.
31. Hobson AR, Willert RP, Matthews PJ, et al. Neurophysiological mechanisms of visceral hypersentivity in non-cardiac chest pain. Gastroenterology 2004;126(suppl 2):A27.
32. Huang SC, Carson RE, Hoffman EJ, et al. Quantitative measurement of local cerebral blood flow in humans by positron computed tomography and 15O-water. J Cereb Blood Flow Metab 1983;3:141-53.
33. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology 1998;114:559-78.
34. Phillips ML, Gregory LJ, Cullen S, et al. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain 2003;126:669-84.
35. Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut 2004;53:1198-206.
36. Drossman DA. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol 2004;2:353-65.
37. Gray DW, Dixon JM, Collin J. The closed eyes sign: an aid to diagnosing nonspecific abdominal pain. BMJ 1988;297:837.
38. Carnett J. Intercostal neuralgia as a cause of abdominal pain and tenderness. Surg Gynaecol Obstet 1926;42:625-32.
39. Svendsen JH, Munck LK, Andersen JR. Irritable bowel syndrome-prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol 1985;20:415-18.
40. Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987;i:963-5.
41. Cai Z, McCaslin PP. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur J Pharmacol 1992;219:53-7.
42. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001;26:21-9.
43. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol 2003;98:750-8.
44. Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003;124:303-17.
45. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003;1:219-28.
46. Guthrie E, Thompson D. Abdominal pain and functional gastrointestinal disorders. BMJ 2002;325:701-3.
47. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo For moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
48. Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999;13(suppl 2):3-14.
49. Gonsalkorale WM, Miller V, Afzal A, et al. Long term benefits of hypnotherapy for irritable bowel syndrome. Cut 2003;52:1623-9.
50. Lea R, Hioughton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-42.
51. Derbyshire SW, Whalley MG, Stenger VA, et al. Cerebral activation during hypnotically induced and imagined pain. Neuroimage 2004;23:392-401.
52. Furlong PL, Aziz Q, Singh KD, et al. Cortical localisation of magnetic fields evoked by oesophageal distension. Electroencephalogr Clin Neurophysiol 1998;108:234-43.
53. Aziz Q, Andersson JL, Valind S, et al. Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology 1997;113:50-9.
54. Silverman DH, Munakata JA, Ennes H, et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64-72.
55. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000;118:842-8.
56. Naliboff BD, Berman S, Chang L, et al. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003;124:1738-47.
57. Verne GN, Himes NC, Robinson ME, et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003;103:99-110.